Trading Signals: FOLD Stock Price Prediction and Forecast (Thu. May. 31, 2007 - Fri. Dec. 22, 2023)(Amicus Therapeutics Inc)
| FOLD latest price $13.5550 (-0.15%) ($13.5550 - $13.5550) on Mon. Jul. 24, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.32% (three month average) | RSI | 71 | Latest Price | $13.5550(-0.15%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | FOLD advances 0.4% a day on average for past five trading days. | Weekly Trend | FOLD advances 5.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support FOLD advance at 0% a week (0% probability) XBI(64%) IBB(58%) ARKG(52%) IWM(41%) IWO(41%) | Factors Impacting FOLD price | FOLD will decline at least -1.16% in a week (0% probabilities). TBT(-33%) UUP(-15%) VXX(-8%) URA(-1%) EDOC(0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.16% (StdDev 2.32%) | Hourly BBV | -0.9 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $13.59(-0.26%) | 10 Day Moving Average | $13.25(2.3%) | 20 Day Moving Average | $12.77(6.15%) | To recent high | -1.1% | To recent low | 26.2% | Market Cap | $3.5b | | | | Amicus Therapeutics, Inc. is a biotechnology company focused on discovering, developing, and delivering medicines for people living with rare metabolic diseases. The company is committed to advancing and expanding a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. Amicus Therapeutics has a portfolio of product opportunities including the first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants; a novel, clinical-stage, treatment paradigm for Pompe disease; and a rare disease gene therapy portfolio. The company was founded on February 4, 2002 and is headquartered in Cranbury, NJ. |